SCHEMBL2992049

SCHEMBL2992049

O=C1C(Cc2ccc(-c3cccnc3)cc2Cl)CCCN1[C@H]1CC[C@H](O)CC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
CYP11B2 P19099 6/20 0.37
CYP11B1 P15538 5/20 0.37
CYP1A2 P05177 2/20 0.37
FPR1 P21462 1/20 0.37
FPR2 P25090 1/20 0.37
CNR1 P21554 1/20 0.37
CCR5 P51681 1/20 0.36
JAK2 O60674 1/20 0.36
F2 P00734 1/20 0.35
PSD A5PKW4 1/20 0.35
P2RX7 Q99572 1/20 0.34
ROCK2 O75116 1/20 0.34
BMPR1A P36894 1/20 0.34
ACVRL1 P37023 1/20 0.34
ACVR1 Q04771 1/20 0.34
HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2985050 1.00 MKNK1 (0.38) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
SCHEMBL2985055 1.00 MKNK1 (0.38) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
SCHEMBL2996682 0.94 MKNK1 (0.39) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
SCHEMBL2996439 0.94 MKNK1 (0.39) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
Hydrochloric Acid SCHEMBL3882202 0.94 MKNK1 (0.39) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
Hydrochloric Acid SCHEMBL3882198 0.94 MKNK1 (0.39) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
SCHEMBL2994371 0.92 CNR1 (0.43) MKNK1MKNK2CYP11B2CYP11B1CYP1A2
SCHEMBL2991869 0.89 HSD11B1 (0.39) CCR5F2P2RX7ROCK2BMPR1A
SCHEMBL2991871 0.89 HSD11B1 (0.39) CCR5F2P2RX7ROCK2BMPR1A
SCHEMBL3001080 0.87 HSD11B1 (0.48) MKNK1MKNK2CYP11B2CYP11B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807072-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2009-01-07 EP claimed
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-11-06 US claimed
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2010-07-22 US disclosed
US-7713979-B2 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-05-11 US disclosed
EP-1807072-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2009-01-07 EP disclosed
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275043-A1 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSDL2, HSD17B1 MKNK1 2995/4885MKNK2 4176/4885CYP11B2 26/4885
US-20100184764-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 MKNK1 1859/4885MKNK2 2818/4885CYP11B2 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.